Phibro Animal Health (PAHC) Accounts Payables (2013 - 2026)

Phibro Animal Health's Accounts Payables history runs 14 years deep, the most recent figure standing at $129.6 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 1.5% year-over-year to $129.6 million; the TTM figure through Mar 2026 stood at $129.6 million (down 1.5% YoY), while the FY2025 annual figure was $138.2 million, up 61.51% from the prior year.
• Accounts Payables was $129.6 million for Q1 2026 at Phibro Animal Health, down from $133.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $138.2 million in Q2 2025 to a low of $73.9 million in Q2 2023.
• Historically, Accounts Payables has averaged $99.1 million across 5 years, with a median of $88.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables declined 22.74% in 2023, then soared 61.51% in 2025.
• A 5-year view of Accounts Payables shows it stood at $80.5 million in 2022, then gained by 7.36% to $86.4 million in 2023, then increased by 15.09% to $99.4 million in 2024, then jumped by 34.04% to $133.3 million in 2025, then dropped by 2.74% to $129.6 million in 2026.
• The last three Accounts Payables figures came in at $129.6 million (Q1 2026), $133.3 million (Q4 2025), and $130.6 million (Q3 2025), per Business Quant data.